ArticleJournal of gastroenterology2016

Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysis.

Hidenori Toyoda et al.PubMed ↗Publisher ↗

No numbers read from the abstract.